marine bacterium, Pseudoalteromonas sp. F-420, collected from the Palauan sea.1) Total synthesis studies by two independent laboratories have described the stereochemistry of the compound as 5S,3'R,9'S,10'R.2,3) Compound 1 was first characterized by its specific inhibitory activity against Gram-negative marine bacteria.1,4) The target molecule of 1 was found to be Na+-translocating NADHquinone reductase (Nqr).4,5) Nqr is widely distributed among Gram-negative marine bacteria, and functions as a primary Na+ pump.6) Compound 1 acts as a noncompetitive inhibitor for a substrate ubiquinone-1, with the inhibition constant of 82pM.5) By using a korormicin-resistant mutant of Vibrio alginolyticus, KR2, Gly140 on NqrB, one of the subunits of the Nqr complex, was shown to be essential to the binding of 1.7) This amino acid residue Gly140 is well conserved among Gram-negative pathogens on which the nqr operon is found in the genome sequence. Korormicin could be used as an antibiotic not only against marine bacteria, but against any bacterium using the primary sodium pump to maintain life.
During a fermentation study of the strain F-420, we found some minor compounds detected in the HPLC chromatogram in a step of the purification of 1. In this report, we describe our isolation of some compounds that The 1H and 13C NMR spectra for these compounds ( Table 1 ). suggested that their planar structures were very similar to that of 1.1) Their IR and UV spectra were substantially identical to those of 1. From HMBC and the result of the FAB-MS analysis, 1a-c were deduced to be (1) 1H-NMR aData from reference 1). OCT. 2003 derivatives of 1, with different alkyl chain lengths at their amide moiety (Fig. 1) . Compound 2 had the molecular formula of 2.87, respectively). This suggests the absence of the epoxide ring in compound 2. COSY indicated that a hydroxyl group was correlated with H-9', but not with H- (2) 13C-NMRa a Multiplicity in parenthesis was determined by DEPT.
b Data from reference 1).
c-i, interchangeable.
VOL. 56 NO. 10 THE JOURNAL OF ANTIBIOTICS 869 the binding of bromine at this carbon. Fig. 1 shows the planar structure of 2 that was established. Compound 3 had the molecular formula of C24H37NO5, one methylene unit difference from 1. HSQC data were shown to be almost identical to each other in the amide part of 1 and 3. However, the lactone moiety lacked a secondary respectively. Fig. 1 shows the planar structure of 3 that was established.
The regiochemistry at the double bonds and the epoxide in compounds 1a-c, 2, and 3 was found from their coupling constants, J4',5', J6',7', and J9',10', respectively, recorded on 1H NMR charts. All derivatives shared conformation with 1: C-4'/C-5', Z; C-6'/C-7', E; C-9'/C-10' (except 2), cis ( Table 2 ). The complete configuration for these new compounds is unknown now.
The strength of the antibacterial activity of these derivatives was compared by using the paper disk method.1)
The result ( a Data from reference 1). Table 3 . Antibacterial Activity of compounds 1, 1a-c, 2, and 3a.
used). Values are diameters in mm of inhibition zone on the agar plate.
b Bacterial strains used were Salinivibrio costicola ATCC33508, Pseudoalteromonas haloplanktis ATCC14393, and E. coil IFO3301.
c S. costicola and P. haloplanktis are marine bacteria characterized by their halophilicity (designated as (+)).
